Biologics Efficacy, Safety Not Significantly Impacted by Comorbidities in Older Adults with Psoriasis
New data indicates that biologic treatments for psoriasis patients were found not to be significantly affected by comorbidities in older patients, widening the understanding of biologic use in different subgroups.
Source: hcplive.com